Search Here

GlaxoSmithKline (GSK) is required to pay $3 million to the widow of Stewart Dolin, who committed suicide in July 2010. The suicide has been caused by a generic anti-depressant that he was taking. Stewart jumped in front of a Blue Line train in the Loop.

GlaxoSmithKline Case Involving Stewart Dolin 

The jury found GlaxoSmithKline responsible for Stewart's suicide. Wendy Dolin, Stewart's widow was awarded $2 million for damages and $1 million for her husband's suffering. The panel that included nine people agreed that paroxetine, which is GlaxoSmithKline's Paxil, was the reason that Stewart killed himself, according to Chicago Sun Times.

A statement from attorneys Michael Baum, Brent Wisner, and Dave Rapoport indicated that GSK already knew that Paxil can cause people to commit suicide. This can happen to people at any age bracket. The statement further indicated that GSK hid the reality from most of its patients taking the medication.

The suit also claimed that GSK was not able to warn Stewart of the possible risk of paroxetine. The drug has been associated with suicidal tendencies to people that take it, especially in adults. GlaxoSmithKline made a claim that the company did not manufacture the pills that Stewart was taking and should not be held responsible.

Judge's Decision On The Case

However, the judge decided that the company is responsible for the drug's label. The company knew that the drug can lead people towards harm, even if the patients take the generic version of the drug. The suit wanted to get $39 million in damages but is contented with the verdict of $3 million.

Meanwhile, Stewart Dolin was 57 when he killed himself. He also was a corporate attorney and a partner at Reed Smith law firm.

Wendy Dolin shared her statement right after the verdict was announced, that this has been a great day for consumers, as reported by Chicago Tribune. She noted that it was always not about the money but rather, about people to be aware of health issues.